SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-18-000069
Filing Date
2018-08-09
Accepted
2018-08-09 17:11:50
Documents
4
Period of Report
2018-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opiant-8xk2q18earningspres.htm 8-K 25676
2 EXHIBIT 99.1 a2018-08x09_opntx2q18finan.htm EX-99.1 28975
3 a20180809opnt2q18fina_image1.gif GRAPHIC 172896
4 a20180809opnt2q18fina_image2.gif GRAPHIC 149104
  Complete submission text file 0001385508-18-000069.txt   499858
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 181006291
SIC: 1000 Metal Mining